Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Sophie ... Kallister ...Teremoto

Mar 26, 2007 09:19AM

Mar 26, 2007 09:47AM

Mar 26, 2007 10:20AM

Mar 26, 2007 10:53AM

Re: Sophie ... Kallister ...Teremoto

posted on Mar 26, 2007 07:02PM
From the recent SB-2

Warrant Shares We Are Registering
We are registering 7,000,000 shares issuable on the exercise of warrants or options issued between April 26, 2004 and June 5, 2006. [which has IMO been the SOP here, get rid of warrants, OS increase.. nothing new]
Additional Shares We Are Registering
We are also registering 11,810,108 shares that are issued and outstanding.
Key Facts
Shares being offered
18,810,108 (4.89% of our shares currently outstanding as of November 30, 2006)
Total shares outstanding prior to the offering as of November 30, 2006
384,322,318
Total shares outstanding assuming completion of the offering
391,322,318


As you can see by the math only 7 mil shares will actually be added to the OS.. not 18 mil

corrections welcomed


Share
New Message
Please login to post a reply